Volumen | 1 |
|
|||||
News | - |
Finanzwerte MACAU
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
38,01M | 3,36M | - | 0 | 263k | 0,08 | 144,52 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Moringa Acquisition
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
26.2.2024 | 23:29 | Edgar (US Regulatory) | Form 8-K - Current report |
26.2.2024 | 23:29 | Edgar (US Regulatory) | Form 8-K - Current report |
22.2.2024 | 14:27 | GlobeNewswire Inc. | Silexion, a Clinical-Stage, Oncology-Focused Biotechnology.. |
14.11.2023 | 22:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
22.8.2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
16.8.2023 | 15:27 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
15.8.2023 | 15:27 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
15.8.2023 | 15:26 | Edgar (US Regulatory) | Form 8-K - Current report |
15.8.2023 | 15:25 | GlobeNewswire Inc. | MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST.. |
14.8.2023 | 22:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10.8.2023 | 22:10 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
10.8.2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Moringa Acquisition
Keine Diskussionen Gefunden.Neuen Thread Erstellen
MACAU Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |